- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
KPC Pharmaceuticals Inc (600422)
The KPC Pharm share price today is 8.38, view SS 600422 stock exchange data. Track the latest KPC Pharm share price with real-time updates on 600422 stock performance including market cap, day range, 52-week range and dividend yield. Access 600422 charts, earnings dates and analyst estimates to support your investment decisions.
Shanghai
Currency in CNY
8.38
-0.15(-1.76%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.36
8.52
52 wk Range
8.13
15.13
600422 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.368.52
52 wk Range
8.1315.13
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.58%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.58%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600422 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
16.15
Upside
+92.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.15
(+92.72% Upside)
Earnings
Latest Release
25-04-2026
EPS / Forecast
-- / --
Revenue / Forecast
836M / --
Compare 600422 to Peers and Sector
Metrics to compare | 600422 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600422PeersSector | |
|---|---|---|---|---|
P/E Ratio | 53.9x | 22.5x | −0.5x | |
PEG Ratio | −0.67 | −0.40 | 0.00 | |
Price/Book | 1.2x | 1.8x | 2.6x | |
Price / LTM Sales | 1.1x | 2.1x | 3.0x | |
Upside (Analyst Target) | 92.7% | 51.3% | 58.6% | |
Fair Value Upside | Unlock | 15.3% | 10.2% | Unlock |
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as well as engages in the wholesale and retail of medicines and equipment. The company offers products in the field of cardiovascular and cerebrovascular, orthopedics series, antimalarial, gynecology, digestive system, and others treatments. It offers its products under Luotai, Tianxuanqing, Artemedine, Artem, and Arco brands. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals,Inc. was founded in 1951 and is based in Kunming, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the KPC Pharm (600422) Share Price Today?
The KPC Pharm share price today is 8.38.
What is the current KPC Pharm (600422) share price and day range?
As of 16-06-2026, the KPC Pharm share price is 8.38, with a previous close of 8.53. The share price has ranged from 8.36 to 8.52 today, while the 52-week range spans from 8.13 to 15.13.
What Is the KPC Pharm Market Cap?
As of today, KPC Pharm market cap is 6.34B.
Does KPC Pharm Pay Dividends? What's The Current Dividend Yield?
The KPC Pharm dividend yield is 3.58%.
What Is the KPC Pharm (600422) Share Price Target?
The average 12-month share price target for KPC Pharm is 16.15, with a high estimate of 16.15 and a low estimate of 16.15. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +92.72% Upside potential.
What Is KPC Pharm's Earnings Per Share (TTM)?
The KPC Pharm EPS (TTM) is 0.16.
When Is the Next KPC Pharm Earnings Date?
KPC Pharm will release its next earnings report on 13-08-2026.
From a Technical Analysis Perspective, Is 600422 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does KPC Pharm Trade On?
KPC Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for KPC Pharm?
The stock symbol for KPC Pharm is "600422."
How Many Times Has KPC Pharm Stock Split?
KPC Pharm has split 3 times.
How Many Employees Does KPC Pharm Have?
KPC Pharm has 5072 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.